OrthoPediatrics [KIDS] vs Boston Scientific [BSX] Detailed Stock Comparison
OrthoPediatrics
NASDAQ
Loading...
Boston Scientific
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: OrthoPediatrics wins in 7 metrics, Boston Scientific wins in 11 metrics, with 0 ties. Boston Scientific appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | OrthoPediatrics | Boston Scientific | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 246.27 | 61.39 | Boston Scientific |
| Price-to-Book Ratio | 1.33 | 6.81 | OrthoPediatrics |
| Debt-to-Equity Ratio | 29.77 | 53.09 | OrthoPediatrics |
| PEG Ratio | -18.01 | 36.97 | OrthoPediatrics |
| EV/EBITDA | -38.43 | 34.98 | OrthoPediatrics |
| Profit Margin (TTM) | -18.92% | 13.55% | Boston Scientific |
| Operating Margin (TTM) | -12.58% | 18.63% | Boston Scientific |
| EBITDA Margin (TTM) | N/A | 18.63% | N/A |
| Return on Equity | -11.49% | 11.55% | Boston Scientific |
| Return on Assets (TTM) | -4.38% | 5.39% | Boston Scientific |
| Free Cash Flow (TTM) | $-41.31M | $2.37B | Boston Scientific |
| 1-Year Return | -29.73% | 35.37% | Boston Scientific |
| Price-to-Sales Ratio (TTM) | 2.15 | 8.26 | OrthoPediatrics |
| Enterprise Value | $509.83M | $164.56B | Boston Scientific |
| EV/Revenue Ratio | 2.31 | 8.90 | OrthoPediatrics |
| Gross Profit Margin (TTM) | 72.07% | 67.65% | OrthoPediatrics |
| Revenue per Share (TTM) | $9 | $13 | Boston Scientific |
| Earnings per Share (Diluted) | $-1.80 | $1.68 | Boston Scientific |
| Beta (Stock Volatility) | 1.12 | 0.66 | Boston Scientific |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
OrthoPediatrics vs Boston Scientific Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| OrthoPediatrics | -1.51% | -7.26% | -12.78% | -18.07% | -23.07% | -17.32% |
| Boston Scientific | 0.17% | -2.15% | 0.71% | -0.15% | -2.86% | 15.39% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| OrthoPediatrics | -29.73% | -65.66% | -63.63% | 0.85% | 0.85% | 0.85% |
| Boston Scientific | 35.37% | 143.66% | 163.38% | 491.74% | 1,782.12% | 264.32% |
Performance & Financial Health Analysis: OrthoPediatrics vs Boston Scientific
| Metric | KIDS | BSX |
|---|---|---|
| Market Information | ||
| Market Cap | $474.14M | $152.83B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 213,870 | 6,224,340 |
| 90 Day Avg. Volume | 170,243 | 7,502,280 |
| Last Close | $18.91 | $103.14 |
| 52 Week Range | $16.59 - $33.14 | $74.01 - $108.94 |
| % from 52W High | -42.94% | -5.32% |
| All-Time High | $73.91 (Nov 01, 2021) | $108.94 (Jul 23, 2025) |
| % from All-Time High | -74.41% | -5.32% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.16% | 0.23% |
| Quarterly Earnings Growth | 0.16% | 1.46% |
| Financial Health | ||
| Profit Margin (TTM) | -0.19% | 0.14% |
| Operating Margin (TTM) | -0.13% | 0.19% |
| Return on Equity (TTM) | -0.11% | 0.12% |
| Debt to Equity (MRQ) | 29.77 | 53.09 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $14.18 | $15.14 |
| Cash per Share (MRQ) | $2.80 | $0.36 |
| Operating Cash Flow (TTM) | $-28,884,000 | $4.28B |
| Levered Free Cash Flow (TTM) | $-17,784,500 | $2.94B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: OrthoPediatrics vs Boston Scientific
| Metric | KIDS | BSX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 246.27 | 61.39 |
| Forward P/E | -18.01 | 36.97 |
| PEG Ratio | -18.01 | 36.97 |
| Price to Sales (TTM) | 2.15 | 8.26 |
| Price to Book (MRQ) | 1.33 | 6.81 |
| Market Capitalization | ||
| Market Capitalization | $474.14M | $152.83B |
| Enterprise Value | $509.83M | $164.56B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.31 | 8.90 |
| Enterprise to EBITDA | -38.43 | 34.98 |
| Risk & Other Metrics | ||
| Beta | 1.12 | 0.66 |
| Book Value per Share (MRQ) | $14.18 | $15.14 |
Financial Statements Comparison: OrthoPediatrics vs Boston Scientific
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | KIDS | BSX |
|---|---|---|
| Revenue/Sales | $52.41M | $4.66B |
| Cost of Goods Sold | $14.15M | $1.45B |
| Gross Profit | $38.26M | $3.21B |
| Research & Development | $2.35M | $443.00M |
| Operating Income (EBIT) | $-10.94M | $937.00M |
| EBITDA | $-4.25M | $1.23B |
| Pre-Tax Income | $-10.46M | $805.00M |
| Income Tax | $196,000 | $133.00M |
| Net Income (Profit) | $-10.66M | $672.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | KIDS | BSX |
|---|---|---|
| Cash & Equivalents | $33.44M | $725.00M |
| Total Current Assets | $232.06M | $7.34B |
| Total Current Liabilities | $37.51M | $5.06B |
| Long-Term Debt | $73.03M | $10.93B |
| Total Shareholders Equity | $347.15M | $22.45B |
| Retained Earnings | $-246.22M | $3.35B |
| Property, Plant & Equipment | N/A | $448.00M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | KIDS | BSX |
|---|---|---|
| Operating Cash Flow | $-1.11M | $513.00M |
| Capital Expenditures | $-4.23M | $-187.00M |
| Free Cash Flow | $-8.38M | $277.00M |
| Debt Repayment | $-126,000 | $-1.31B |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | KIDS | BSX |
|---|---|---|
| Shares Short | 1.12M | 19.57M |
| Short Ratio | 8.93 | 2.65 |
| Short % of Float | 0.07% | 0.01% |
| Average Daily Volume (10 Day) | 213,870 | 6,224,340 |
| Average Daily Volume (90 Day) | 170,243 | 7,502,280 |
| Shares Outstanding | 24.22M | 1.47B |
| Float Shares | 16.78M | 1.48B |
| % Held by Insiders | 0.33% | 0.00% |
| % Held by Institutions | 0.71% | 0.93% |
Dividend Analysis & Yield Comparison: OrthoPediatrics vs Boston Scientific
| Metric | KIDS | BSX |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |